Related Experiment Video
Updated: Jun 21, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor
Yong Zhang1, Donald Y M Leung, Steven K Nordeen
1Department of Pediatrics, National Jewish Health, Denver, Colorado 80206, USA.
Abstract:
Although glucocorticoids suppress proliferation of many cell types and are used in the treatment of certain cancers, trials of glucocorticoid therapy in breast cancer have been a disappointment. Another suggestion that estrogens may affect glucocorticoid action is that the course of some inflammatory diseases tends to be more severe and less responsive to corticosteroid treatment in females. To date, the molecular mechanism of cross-talk between estrogens and glucocorticoids is poorly understood. Here we show that, in both MCF-7 and T47D breast cancer cells, estrogen inhibits glucocorticoid induction of the MKP-1 (mitogen-activated protein kinase phosphatase-1) and serum/glucocorticoid-regulated kinase genes. Estrogen did not affect glucocorticoid-induced glucocorticoid receptor (GR) nuclear translocation but reduced ligand-induced GR phosphorylation at Ser-211, which is associated with the active form of GR. We show that estrogen increases expression of protein phosphatase 5 (PP5), which mediates the dephosphorylation of GR at Ser-211. Gene knockdown of PP5 abolished the estrogen-mediated suppression of GR phosphorylation and induction of MKP-1 and serum/glucocorticoid-regulated kinase. More importantly, after PP5 knockdown estrogen-promoted cell proliferation was significantly suppressed by glucocorticoids. This study demonstrates cross-talk between estrogen-induced PP5 and GR action. It also reveals that PP5 inhibition may antagonize estrogen-promoted events in response to corticosteroid therapy.
Insights
Estrogen hinders glucocorticoid effectiveness in breast cancer cells by reducing glucocorticoid receptor (GR) activity. Inhibiting protein phosphatase 5 (PP5) restores glucocorticoid sensitivity, suggesting a new therapeutic target.
Area of Science:
- Molecular Endocrinology
- Cancer Biology
- Cell Signaling
Background:
- Glucocorticoids suppress cell proliferation but have limited efficacy in breast cancer treatment.
- Estrogen's influence on glucocorticoid action and inflammatory diseases suggests potential cross-talk.
- The molecular mechanisms underlying estrogen-glucocorticoid interactions remain largely unknown.
Purpose of the Study:
- To investigate the molecular mechanisms of cross-talk between estrogen and glucocorticoid signaling in breast cancer cells.
- To determine how estrogen affects glucocorticoid receptor (GR) activity and gene induction.
- To explore the role of protein phosphatase 5 (PP5) in mediating these interactions.
Main Methods:
- Utilized MCF-7 and T47D breast cancer cell lines.
- Assessed glucocorticoid-induced gene expression (MKP-1, SGK) and GR phosphorylation (Ser-211).
- Employed gene knockdown techniques for protein phosphatase 5 (PP5) and analyzed effects on GR activity and cell proliferation.
Main Results:
- Estrogen inhibited glucocorticoid induction of MKP-1 and SGK genes in breast cancer cells.
- Estrogen reduced GR phosphorylation at Ser-211, a marker of GR activity, without affecting nuclear translocation.
- Estrogen increased PP5 expression, which dephosphorylates GR at Ser-211; PP5 knockdown restored GR activity and glucocorticoid-mediated suppression of estrogen-promoted proliferation.
Conclusions:
- Estrogen-induced PP5 mediates cross-talk by dephosphorylating and inactivating the glucocorticoid receptor (GR).
- PP5 inhibition can antagonize estrogen-promoted cell proliferation, restoring glucocorticoid sensitivity.
- Targeting PP5 may offer a strategy to enhance corticosteroid therapy efficacy in estrogen-responsive breast cancers.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
GPCR Desensitization
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Cushing Syndrome II: Pathophysiology
Amplifying Signals via Enzymatic Cascade
